Greenbrook Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Greenbrook is a leading provider of Transcranial Magnetic Stimulation (TMS), a non-invasive and FDA-approved treatment for depression & OCD. We also provide Spravato®, a non-invasive and FDA-cleared nasal esketamine spray treatment for depression. We are committed to transforming lives through innovative mental health solutions without the side effects of taking medications. Our licensed providers and expertly trained clinicians work closely with patients and their physicians to create a treatme

Company Highlights
Year Founded

2011

icon-altEmployees

356

Location (HQ)

USA

Monthly Website Visitors

4.9K

Last Funding Round

Post Ipo Equity

icon-altMoM Headcount Growth

0.56%

icon-altYoY Headcount Growth

24.9%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Mental Health Care